Agenus | AGEN - Koszty Sprzedaży





Koszty Sprzedaży Zmiana Data
AbbVie USD 4.55B 757M 2025-12
Agenus USD 642K 399K 2025-09
Amgen USD 1.79B 128M 2025-12
AstraZeneca USD 3.27B 471M 2025-12
Bristol-Myers Squibb USD 4.92B 657M 2025-12
Celldex Therapeutics USD 54.2M 8.94M 2025-06
CSL USD 3.87B 2.08B 2025-12
Eli Lilly USD 3.37B 363.7M 2025-12
Gilead Sciences USD 1.62B 50M 2025-12
GlaxoSmithKline GBP 2.61B 377M 2025-12
Glaxosmithkline GBP 3.47B 461.37M 2025-12
Incyte USD 121.18M 22.18M 2025-12
Intrexon USD 1.01M 344K 2024-06
J&J USD 8.07B 103M 2026-03
Jiangsu Hengrui CNY 1.17B 86.74M 2025-12
Karyopharm Therapeutics USD 1.48M 35.95M 2025-12
MacroGenics USD 10.12M 34.18M 2025-12
Merck EUR 2.29B 183M 2025-12
Merck USD 3.32B 531M 2025-12
Novartis USD 3.54B 3M 2025-12
Novavax USD 22.1M 608K 2025-12
Pfizer USD 6.29B 2.12B 2025-12
Regeneron Pharmaceuticals USD 584.6M 63M 2025-12
Rigel Pharmaceuticals USD 8.03M 5.22M 2024-09
Sangamo BioSciences 2.42M 1.11M 2024-06
Veracyte USD 39.28M 1.93M 2025-12